Cypherpunk Technologies (NASDAQ:CYPH) Given “Overweight” Rating at Cantor Fitzgerald

Cypherpunk Technologies (NASDAQ:CYPH)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $1.60 target price on the stock. Cantor Fitzgerald’s price target would suggest a potential downside of 1.84% from the company’s current price.

Several other equities analysts have also weighed in on the stock. Wall Street Zen raised shares of Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. Weiss Ratings raised shares of Cypherpunk Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 17th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $1.60.

Cypherpunk Technologies Stock Performance

Shares of CYPH stock opened at $1.63 on Thursday. Cypherpunk Technologies has a 52-week low of $0.27 and a 52-week high of $3.70. The stock has a market cap of $175.66 million, a price-to-earnings ratio of 2.91 and a beta of 0.09. The firm’s 50-day moving average is $0.77 and its 200-day moving average is $0.81.

Cypherpunk Technologies (NASDAQ:CYPH) last posted its earnings results on Wednesday, August 12th. The company reported $0.18 earnings per share for the quarter.

Institutional Investors Weigh In On Cypherpunk Technologies

Several institutional investors have recently made changes to their positions in the stock. Acadian Asset Management LLC boosted its stake in shares of Cypherpunk Technologies by 470.4% in the first quarter. Acadian Asset Management LLC now owns 1,280,531 shares of the company’s stock valued at $389,000 after buying an additional 1,056,047 shares during the period. Sequoia Financial Advisors LLC bought a new position in Cypherpunk Technologies during the 4th quarter worth $56,000. HighTower Advisors LLC acquired a new position in Cypherpunk Technologies in the 4th quarter valued at $59,000. Simplify Asset Management Inc. acquired a new position in Cypherpunk Technologies in the 4th quarter valued at $2,172,000. Finally, Texas Capital Bank Wealth Management Services Inc bought a new stake in shares of Cypherpunk Technologies during the 4th quarter valued at $121,000. 30.46% of the stock is currently owned by institutional investors.

About Cypherpunk Technologies

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.